Semax and SS-31 stacks on TikTok: separating peptide facts from vendor hype

A recent TikTok clip features a creator pointing viewers to a vendor link in their bio, teasing a peptide stack with the hashtags #peptide, #semax, #ss31, and #peptidestack. The video implies that combining Semax and SS-31 (Elamipretide) offers some kind of cognitive or mitochondrial benefit, but the clip provides no specifics—no dosages, no protocols, no citations. As with many short-form peptide videos, the goal is to drive traffic to a sales page rather than to educate. This article examines what the research actually says about these two compounds and why a 15-second clip is insufficient for making informed decisions.

What the clip is claiming

The creator’s caption and on-screen text suggest that Semax and SS-31 are worth stacking, and that the vendor in their bio is the place to get them. The implied claim is that this combination is beneficial—likely for cognitive enhancement (Semax) and mitochondrial health (SS-31)—but no evidence is presented. The video is essentially an endorsement of a product link, not a scientific explanation.

What the research neighborhood actually covers

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) that has been studied in Russia and Eastern Europe for its potential neuroprotective and nootropic effects. Research, mostly preclinical or small human studies, suggests it may influence brain-derived neurotrophic factor (BDNF) and other pathways related to learning and memory. However, most studies are not large-scale, placebo-controlled trials, and Semax is not approved by the FDA for any use.

SS-31, also known as Elamipretide, is a mitochondrial-targeted peptide that has been investigated for conditions like heart failure and mitochondrial myopathy. It is thought to interact with cardiolipin on the inner mitochondrial membrane, potentially improving energy production and reducing oxidative stress. Clinical trials are ongoing, but as of now, SS-31 is not approved for general use.

There is no published research on combining Semax and SS-31. The idea of stacking them appears to be based on theoretical complementary mechanisms—one for brain function, one for cellular energy—but no empirical evidence supports this specific combination.

Limits, missing context, and what a 15-second clip cannot show

A short TikTok clip cannot convey the complexity of peptide research. It omits crucial details such as appropriate dosing, potential side effects, interactions, and the fact that these compounds are not approved for human use outside of clinical trials. The creator also fails to disclose that they may be earning a commission from the vendor link, which is a conflict of interest. Without proper context, viewers might assume that stacking these peptides is safe and effective, when in reality, the evidence is preliminary and the risks are unknown.

How this maps to named research compounds

Both Semax and SS-31 are listed in the catalog as research-use-only peptides. Semax is available as a standalone product, and SS-31 (Elamipretide) is also listed. The catalog does not offer a pre-made Semax + SS-31 blend, so any stacking would require separate purchases and self-directed research. The clip’s mention of a “peptidestack” is vague and does not align with any specific catalog product.

Research-use caveat

All peptides sold by peptides-pro are intended for laboratory research and in vitro testing only. They are not for human or veterinary use. Researchers must adhere to institutional guidelines and ensure proper handling. The information in this article is for educational purposes and does not constitute medical advice.

Open the full video fact-check page (transcript, takeaways, embedded clip).